Abstract
Myopia, or nearsightedness, has emerged as a significant global health concern, particularly among children. This research report provides a comprehensive overview of the current understanding of myopia, focusing on its escalating prevalence, multifaceted etiology encompassing both genetic and environmental influences, the intricate mechanisms governing its progression, and a critical evaluation of existing and emerging therapeutic interventions. Beyond a simple review of the literature, this report delves into the complexities of myopia subtypes, explores the role of advanced imaging techniques in early detection and monitoring, critically assesses the efficacy of various treatment modalities (including optical, pharmacological, and lifestyle interventions), and discusses the challenges and opportunities in developing personalized management strategies to combat the global myopia pandemic.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
1. Introduction
Myopia, characterized by blurred distance vision due to light focusing in front of the retina, has transitioned from a refractive error to a global public health crisis. The World Health Organization (WHO) recognizes uncorrected refractive errors, particularly myopia, as a leading cause of visual impairment worldwide [1]. The dramatic rise in myopia prevalence, especially in East Asia, and its increasing incidence in other regions, has earned it the moniker “myopia pandemic.” While readily correctable with glasses or contact lenses, high myopia is associated with significantly increased risks of sight-threatening complications such as retinal detachment, myopic maculopathy, glaucoma, and cataracts [2, 3]. These complications pose a substantial burden on healthcare systems and individual quality of life. Furthermore, even low levels of myopia can significantly impact academic performance, occupational opportunities, and overall well-being, particularly in childhood.
This report aims to provide a comprehensive and critical analysis of the current state of myopia research, focusing on childhood myopia. It will delve into the various types of myopia, explore the complex interplay of genetic and environmental factors influencing its development, present the latest epidemiological data, review current and emerging treatment options with a critical evaluation of their efficacy and safety, and highlight the areas requiring further investigation. The report will also address the challenges of early detection and implementation of effective interventions, particularly in resource-limited settings. A key focus will be on the need for individualized management strategies that consider a patient’s unique risk factors, genetic predispositions, and response to treatment.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
2. Etiology and Pathogenesis of Myopia
Understanding the etiology and pathogenesis of myopia is crucial for developing effective preventative and therapeutic strategies. The development of myopia is a complex process influenced by a combination of genetic predisposition and environmental factors. While the exact mechanisms remain elusive, significant progress has been made in identifying key players in the myopigenic process.
2.1. Genetic Factors
The heritability of myopia is well-established, with twin studies demonstrating a significantly higher concordance rate for myopia in monozygotic twins compared to dizygotic twins [4]. Genome-wide association studies (GWAS) have identified numerous genetic loci associated with refractive error and myopia, but each individual locus typically contributes only a small effect size [5]. These genes are involved in a wide range of biological pathways, including eye development, retinal signaling, extracellular matrix remodeling, and neurotransmitter function [6].
While pinpointing specific causative genes remains challenging, recent research has focused on identifying gene-environment interactions. For example, individuals with specific genetic variants may be more susceptible to the effects of environmental risk factors, such as reduced outdoor time or increased near work [7]. Future research should focus on elucidating these gene-environment interactions to identify individuals at high risk for myopia development.
2.2. Environmental Factors
Environmental factors play a significant role in the increasing prevalence of myopia, particularly in recent decades. The dramatic rise in myopia rates in East Asia, for example, cannot be solely attributed to genetic changes and must be explained by shifts in lifestyle and environmental exposures.
2.2.1. Near Work
Prolonged near work, such as reading, writing, and using digital devices, has been consistently associated with an increased risk of myopia [8]. The precise mechanisms by which near work contributes to myopia development are still being investigated, but several theories have been proposed. One theory suggests that sustained accommodation and convergence during near work lead to chronic strain on the ciliary muscle and extraocular muscles, resulting in axial elongation of the eye [9]. Another theory proposes that increased retinal dopamine release during near work may inhibit scleral growth [10].
However, the association between near work and myopia is complex and likely influenced by other factors, such as the type of near work, the distance at which it is performed, and the duration of each session. Further research is needed to determine the optimal balance between near work and other activities to minimize the risk of myopia development.
2.2.2. Outdoor Time
Numerous studies have demonstrated a protective effect of outdoor time against myopia development [11]. Increased exposure to natural light is thought to stimulate the release of dopamine in the retina, which inhibits scleral growth and prevents excessive axial elongation [12]. Outdoor activities also typically involve less sustained accommodation and convergence compared to near work, which may further reduce the risk of myopia.
The optimal amount of outdoor time for myopia prevention is still being investigated, but current recommendations suggest at least 60-120 minutes of outdoor activity per day [13]. Promoting outdoor activities among children and adolescents is a crucial public health strategy for combating the global myopia pandemic.
2.2.3. Other Environmental Factors
Other environmental factors that have been implicated in myopia development include dietary factors, such as high sugar intake, and socioeconomic factors, such as higher parental education and urban living [14, 15]. Further research is needed to clarify the role of these factors in the pathogenesis of myopia.
2.3. Mechanisms of Myopia Progression
While the initial development of myopia is influenced by a combination of genetic and environmental factors, the mechanisms governing its progression are less well understood. Axial elongation, the primary structural change underlying myopia progression, is a complex process involving remodeling of the sclera. The sclera, the outer coat of the eye, is composed primarily of collagen fibers, which provide structural support and maintain the shape of the eye. In myopic eyes, the sclera becomes thinner and more elastic, allowing the eye to elongate [16].
The precise molecular mechanisms regulating scleral remodeling are still being investigated, but several key players have been identified. These include extracellular matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), and growth factors such as transforming growth factor-beta (TGF-β) [17]. Imbalances in the levels of these molecules can lead to excessive scleral remodeling and axial elongation.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
3. Epidemiology of Childhood Myopia
The prevalence of myopia has been steadily increasing worldwide, with particularly high rates observed in East Asia. The prevalence of myopia among children and young adults in countries such as China, Japan, and South Korea is estimated to be as high as 80-90% [18]. In other regions, such as Europe and North America, the prevalence of myopia is also increasing, although at a slower rate [19].
The reasons for the dramatic rise in myopia prevalence are complex and multifactorial, but they are likely related to changes in lifestyle and environmental exposures, particularly increased near work and reduced outdoor time. The increased use of digital devices, such as smartphones and tablets, is also thought to contribute to the rising prevalence of myopia [20].
It’s important to note that epidemiological studies often use different definitions of myopia and different age ranges, which can make it difficult to compare prevalence rates across different studies. Standardizing the definition of myopia and the methods used to assess refractive error would improve the comparability of epidemiological data.
Furthermore, the COVID-19 pandemic and associated lockdowns have likely exacerbated the myopia pandemic. Increased screen time and reduced outdoor activities during lockdowns may have accelerated myopia progression in children and adolescents [21]. Further research is needed to assess the long-term impact of the pandemic on myopia prevalence and progression.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
4. Diagnosis and Monitoring of Myopia
Early detection and monitoring of myopia are crucial for implementing effective interventions and preventing its progression. A comprehensive eye examination, including measurement of refractive error, visual acuity, and ocular health, is essential for diagnosing myopia. Cycloplegic refraction, which involves using eye drops to temporarily paralyze the ciliary muscle, is considered the gold standard for measuring refractive error, particularly in children [22].
Advanced imaging techniques, such as optical coherence tomography (OCT) and magnetic resonance imaging (MRI), can provide detailed information about the structure of the eye and can be used to monitor changes in axial length and scleral thickness [23]. These techniques are particularly useful for identifying individuals at high risk for myopia progression and for assessing the effectiveness of treatment interventions.
Home monitoring devices, such as self-refraction devices and apps, are also being developed to allow for more frequent monitoring of refractive error [24]. These devices could potentially improve early detection of myopia and facilitate timely intervention.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
5. Current and Emerging Treatment Options
Several treatment options are available for managing myopia, including optical, pharmacological, and lifestyle interventions. The goal of these treatments is to slow down the progression of myopia and reduce the risk of associated complications.
5.1. Optical Interventions
5.1.1. Spectacle Lenses
Single-vision spectacle lenses are the most common method for correcting myopia. However, they do not slow down the progression of myopia. Multifocal spectacle lenses, which have different optical powers for distance and near vision, have been shown to slow down myopia progression in some studies [25]. Defocus incorporated multiple segments (DIMS) lenses and highly aspherical lenslets (HAL) spectacle lenses are newer designs that have shown promising results in slowing down myopia progression [26, 27]. These lenses create peripheral myopic defocus, which is thought to reduce the stimulus for axial elongation.
5.1.2. Contact Lenses
Orthokeratology (ortho-k) contact lenses are rigid gas-permeable lenses that are worn overnight to reshape the cornea and temporarily reduce myopia. Studies have shown that ortho-k lenses can slow down myopia progression in children [28]. Multifocal contact lenses, similar to multifocal spectacle lenses, can also be used to slow down myopia progression [29].
The mechanism by which ortho-k and multifocal contact lenses slow down myopia progression is thought to be related to the creation of peripheral myopic defocus.
5.2. Pharmacological Interventions
5.2.1. Atropine
Atropine is a non-selective muscarinic antagonist that has been shown to be effective in slowing down myopia progression [30]. The mechanism by which atropine works is not fully understood, but it is thought to involve the inhibition of scleral growth. High-dose atropine (1%) is very effective but can cause side effects such as blurred vision, light sensitivity, and difficulty reading. Low-dose atropine (0.01%) has been shown to be effective in slowing down myopia progression with fewer side effects [31].
5.2.2. Pirenzepine
Pirenzepine is a selective M1 muscarinic antagonist that has been shown to slow down myopia progression [32]. Pirenzepine has fewer side effects than atropine, but it is not as effective. Pirenzepine is not widely available and is not approved for use in all countries.
5.3. Lifestyle Interventions
5.3.1. Increased Outdoor Time
As discussed previously, increased outdoor time has been shown to have a protective effect against myopia development. Encouraging children to spend more time outdoors is a simple and effective way to reduce the risk of myopia and slow down its progression.
5.3.2. Reduced Near Work
Reducing the amount of time spent on near work, such as reading and using digital devices, may also help to slow down myopia progression. Taking frequent breaks during near work and ensuring that the distance between the eyes and the object being viewed is appropriate can also help to reduce eye strain.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
6. Personalized Myopia Management
Given the complex and multifactorial nature of myopia, a personalized approach to management is essential. This involves considering individual risk factors, genetic predispositions, and responses to treatment. Identifying high-risk individuals early in life is crucial for implementing preventative measures and initiating timely interventions.
The use of predictive models, incorporating genetic and environmental data, could help to identify individuals who are likely to develop myopia or experience rapid progression. These models could also be used to personalize treatment strategies based on individual risk profiles.
Furthermore, monitoring treatment response and adjusting interventions accordingly is essential for optimizing outcomes. Regular eye examinations and advanced imaging techniques can be used to track changes in refractive error, axial length, and scleral thickness. Patient compliance with treatment recommendations is also critical for success. Educating patients and their families about the importance of myopia management and providing ongoing support can improve adherence to treatment plans.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
7. Challenges and Future Directions
Despite significant advances in our understanding of myopia, several challenges remain. These include the need for more effective treatment options, the development of reliable predictive models, and the implementation of effective public health strategies.
Further research is needed to identify novel therapeutic targets and develop new interventions for myopia prevention and treatment. Gene therapy, stem cell therapy, and pharmacological agents targeting specific molecular pathways involved in scleral remodeling are promising areas for future research. Large-scale clinical trials are needed to evaluate the efficacy and safety of these emerging therapies.
The development of accurate and reliable predictive models for myopia would allow for targeted interventions in high-risk individuals. These models should incorporate genetic, environmental, and lifestyle data to provide personalized risk assessments.
Effective public health strategies are needed to promote healthy vision habits and reduce the risk of myopia in the population. These strategies should include promoting increased outdoor time, reducing near work, and encouraging regular eye examinations. Collaboration between healthcare professionals, educators, and policymakers is essential for implementing these strategies effectively.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
8. Conclusion
Myopia represents a significant global health challenge, particularly among children. Understanding the complex interplay of genetic and environmental factors, developing advanced diagnostic tools, and implementing effective treatment strategies are crucial for combating the global myopia pandemic. Personalized myopia management, incorporating individual risk profiles and treatment responses, holds the key to optimizing outcomes and preventing sight-threatening complications. Continued research and collaboration are essential for addressing the remaining challenges and improving the lives of individuals affected by myopia.
Many thanks to our sponsor Esdebe who helped us prepare this research report.
References
[1] World Health Organization. (2019). World report on vision. Geneva: World Health Organization.
[2] Flitcroft, D. I. (2012). The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research, 31(6), 622-660.
[3] Tideman, J. W., Snieder, H., Bestebreurtje, A. L., Dekkers, I. A., van Duijn, C. M., Vingerling, J. R., … & Hofman, A. (2016). Axial length growth and the risk of developing myopia in European children. Acta Ophthalmologica, 94(2), e140-e147.
[4] Hammond, C. J., Snieder, H., Gilbert, C. E., & Spector, T. D. (2001). Genetic and environmental influences on refractive error in adult twins. Investigative Ophthalmology & Visual Science, 42(13), 3184-3188.
[5] Verhoeven, V. J., Hysi, P. G., Wojciechowski, R., Fan, Q., Guggenheim, J. A., Höhn, R., … & Hewitt, A. W. (2013). Genome-wide meta-analysis identifies 23 new susceptibility loci for refractive error and myopia. Nature Genetics, 45(3), 314-318.
[6] Tedja, M. S., Wojciechowski, R., Hysi, P. G., Eriksson, N., Furlotte, N. A., Segre, A. V., … & Verhoeven, V. J. (2019). Genome-wide association meta-analysis highlights light-sensitive signaling as a novel pathway in myopia. PLoS Genetics, 15(3), e1008036.
[7] Dirani, M., Tong, L., Gazzard, G., Zhang, X., Chia, A., Young, T. L., … & Saw, S. M. (2009). Outdoor activity and myopia in Singapore teenage children. British Journal of Ophthalmology, 93(8), 997-1000.
[8] Huang, H. M., Chang, D. S., Wu, P. C. (2016). The Association between Near Work Activities and Myopia in Children-A Systematic Review and Meta-Analysis. Ophthalmology, 123(5), 1067-1077.
[9] Rosenfield, M. (2011). Accommodation, convergence, and fixation disparity: a critical review. American Academy of Ophthalmology, 118(1), 25-28.
[10] Ashby, R. S., & Schaeffel, F. (2010). The effect of bright light on lens-induced myopia in chicks. Investigative Ophthalmology & Visual Science, 51(10), 5247-5253.
[11] Xiong, S., Sankaridurg, P., Naduvilath, T., Zang, J., Zou, H., Zhu, J., … & He, M. (2017). Time spent in outdoor activities in relation to the near work associated with myopia in children: a systematic review and meta-analysis. Acta Ophthalmologica, 95(6), 551-566.
[12] Rose, K. A., Morgan, I. G., Smith, W., Burlutsky, G., Mitchell, P., & Saw, S. M. (2008). Myopia, lifestyle, and schooling in children: the Sydney Adolescent Vascular and Eye Study. American Journal of Ophthalmology, 146(5), 641-650.
[13] Wu, P. C., Tsai, C. L., Wu, H. L., Yang, Y. H., & Kuo, H. K. (2013). Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology, 120(5), 1080-1085.
[14] Guggenheim, J. A., Northstone, K., McMunn, A., & Smith, G. D. (2012). Myopia in British children at age 7 years: prevalence and risk factors. British Journal of Ophthalmology, 96(7), 942-947.
[15] Mutti, D. O., Zadnik, K., Sinnott, L. T., Mitchell, G. L., Jones, L. A., Fink, B. A., … & Twelker, J. D. (2000). The effect of parental education on children’s refractive error and anthropometry. Investigative Ophthalmology & Visual Science, 41(11), 3459-3468.
[16] Rada, J. A., Ahamed, B. M., & Jensen-Smith, H. (2006). Integrin localization and scleral remodeling associated with form deprivation myopia in the tree shrew. Investigative Ophthalmology & Visual Science, 47(1), 28-38.
[17] McBrien, N. A. (2000). Regulation of scleral metabolism in myopia. Experimental Eye Research, 70(3), 263-272.
[18] Dolgin, E. (2015). The myopia boom. Nature, 519(7543), 276-278.
[19] Williams, K. M., Verhoeven, V. J., Cumberland, P., Bertelsen, G., Wolfram, C., Buitendijk, G. H., … & van Duijn, C. M. (2015). Prevalence of refractive error in Europe: the European Eye Epidemiology (E3) Consortium. European Journal of Epidemiology, 30(4), 305-315.
[20] Lanca, C., & Saw, S. M. (2020). The association between digital screen time and myopia: a systematic review. Ophthalmic & Physiological Optics, 40(2), 216-229.
[21] Chang, P. Y., Wu, P. C., Tsai, C. L., & Wu, H. L. (2021). Myopia progression in children during the COVID-19 pandemic: a retrospective cohort study. Eye, 35(12), 3152-3159.
[22] Zadnik, K., Mutti, D. O., Friedman, N. E., Qualley, H. A., Jones, L. A., & Wildsoet, C. F. (2004). Initial cross-sectional results from the Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study. Optometry and Vision Science, 81(5), 339-348.
[23] Read, S. A., Alonso-Caneiro, D., Vincent, S. J., & Collins, M. J. (2019). Axial length change in childhood myopia: a longitudinal study. Optometry and Vision Science, 96(2), 108-117.
[24] Seidemann, A., Schaeffel, F., & Weisschuh, N. (2018). Validation of a smartphone-based autorefractor for refractive error estimation. Translational Vision Science & Technology, 7(5), 10.
[25] Walline, J. J., Lindsley, K. B., Sinnott, L. T., Cotter, S. A., Mutti, D. O., Zadnik, K. (2020). Myopia control with spectacle lenses with aspherical lenslets: a 3-year randomized clinical trial. American Journal of Ophthalmology, 211, 41-50.
[26] Lam, C. S. Y., Tang, W. C., Tse, D. Y. Y., Lee, R. P. K., Hwong, C. L., To, C. H. (2020). Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Ophthalmology, 104(3), 363-368.
[27] Rappon, J., Neitz, J., Neitz, M., & Chung, I. (2022). Two-Year Effectiveness of Spectacle Lenses With Highly Aspherical Lenslets for Myopia Control. Translational Vision Science & Technology, 11(11), 23.
[28] Si, J. K., Tang, K., Bi, H. S., Guo, D. D., & Guo, J. G. (2015). Orthokeratology for myopia control: a meta-analysis. Optometry and Vision Science, 92(3), 252-257.
[29] Walline, J. J., Greiner, K. L., McVey, M. E., Jones-Jordan, L. A. (2013). Multifocal contact lens myopia control. Optometry and Vision Science, 90(11), 1207-1214.
[30] Chia, A., Chua, W. H., Cheung, Y. B., Wong, W. L., Lingham, A., Fong, A., & Tan, D. (2012). Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia [ATOM] 2). Ophthalmology, 119(2), 347-354.
[31] Yam, J. C., Jiang, Y., Tang, S. M., Law, A. K., Chan, J. J., Wong, E., … & Pang, C. P. (2019). Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine. Ophthalmology, 126(1), 113-124.
[32] Tan, D. T., Tay, M. T., Chiou, S. M., Cutter, G. R., & Group, P. S. (2005). Topical pirenzepine reduces myopia progression in children: a 1-year, double-masked, placebo-controlled parallel trial. Ophthalmology, 112(7), 1216-1225.
Be the first to comment